TG Therapeutics Inc
(FRA:NKB2)
€
33.42
+0.32 (+0.95%)
Market Cap: 5.18 Bil
Enterprise Value: 5.07 Bil
PE Ratio: 157.96
PB Ratio: 25.27
GF Score: 76/100 TG Therapeutics Inc (FRA:NKB2) Transcripts
- 1